Evidence map›Paper›PMID 31662368›Full record

ArticleBMJ open2019

Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study.

Sympascho Young, Sierra Williams, Michael Otterstatter, Jennifer Lee, Jane Buxton

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Canadian national consensus guidelines for naloxone prescribing by pharmacists.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sympascho YoungFaculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Sierra WilliamsHarm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
Michael OtterstatterHarm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
Jennifer LeeSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Jane BuxtonHarm Reduction, BC Centre for Disease Control, Vancouver, British Columbia, Canada Jane.Buxton@bccdc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study describes the 2016 expansion of the British Columbia Take Home Naloxone (BCTHN) programme quantitatively and explores the challenges, facilitators and successes during the ramp up from the perspectives of programme stakeholders.

designMixed-methods study.

settingThe BCTHN programme was implemented in 2012 to reduce opioid overdose deaths by providing naloxone kits and overdose recognition and response training in BC, Canada. An increase in the number of overdose deaths in 2016 in BC led to the declaration of a public health emergency and a rapid ramp up of naloxone kit production and distribution. BCTHN distributes naloxone to the five regional health authorities of BC.

participantsFocus groups and key informant interviews were conducted with 18 stakeholders, including BC Centre for Disease Control staff, urban and rural site coordinators, and harm reduction coordinators from the five regional health authorities across BC. PRIMARY AND SECONDARY OUTCOME MEASURES: Take Home Naloxone (THN) programme activity, qualitative themes and lessons learnt were identified.

resultsIn 2016, BCTHN responded to a 20-fold increase in demand of naloxone kits and added over 300 distribution sites. Weekly numbers of overdose events and overdose deaths were correlated with increases in THN kits ordered the following week, during 2013-2017. Challenges elicited include forecasting demand, operational logistics, financial, manpower and policy constraints. Facilitators included outsourcing kit production, implementing standing orders and policy changes in naloxone scheduling, which allowed for easier hiring of staff, reduced paperwork and expanded client access.

conclusionFor THN programmes preparing for potential increases in naloxone demand, we recommend creating an online database, implementing standing orders and developing online training resources for standardised knowledge translation to site staff and clients.

Indexed as

Public HealthAnalgesics, OpioidBritish ColumbiaDelivery of Health CareDrug OverdoseHealth PolicyHealth Services AccessibilityHumansNaloxoneNarcotic AntagonistsOpioid EpidemicQualitative ResearchAnalgesics, OpioidNaloxoneNarcotic Antagonistsknowledge translationmix methodsopioid crisispublic healthtake home naloxone

Identifiers

PMID31662368
PMCPMC6830612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.